Bianca Denise Santomasso MD

Neurology•New York, NY

Neurooncology

Assistant Attending

Request appointment

160 East 53rd StreetNew York, NY 10022
Book by Phone+1(347) 836-4940

Overview of Dr. Santomasso

Dr. Bianca Santomasso is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 18 years. She is one of 72 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 60 publications and over 500 citings.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2009 - 2013
Weill Cornell MedicineClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2013 - 2028
NJ State Medical License 2020 - 2027
American Board of Psychiatry and Neurology Neurology
UCNSNeuro-Oncology

Publications & Presentations

PubMed

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy.
Miguel-Angel Perales, Jorg Dietrich, Juliane Gust, Bianca Santomasso, Kai Rejeski
Transplantation and Cellular Therapy. 2026-10-01
Robust CD4CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
Eric M Jurgens, Sneha Mitra, Kevin Herrera, David Nemirovsky, Brenden Bready
Science Translational Medicine. 2026-07-29
1 citations
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTI...
Paula Rodríguez-Otero, Jaime Gállego Pérez-Larraya, Yi Lin, Jorg Dietrich, Niels W C J van de Donk
Clinical Lymphoma, Myeloma & Leukemia. 2026-07-01

Abstracts/Posters

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Neurotoxicity From CAR T-Cell Therapy: Why It Happens, How to Manage It, and Who Is at Risk?
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Incysus Announces Formation of Scientific Advisory BoardAugust 24th, 2017
Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory BoardJanuary 12th, 2017

Grant Support

Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell TherapySLOAN-KETTERING INST CAN RESEARCH2024–2029